207 related articles for article (PubMed ID: 15154874)
1. Extracorporeal albumin dialysis.
Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
[TBL] [Abstract][Full Text] [Related]
2. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
3. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
4. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
Marangoni R
G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
[TBL] [Abstract][Full Text] [Related]
5. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
Klammt S; Mitzner SR; Stange J; Loock J; Heemann U; Emmrich J; Reisinger EC; Schmidt R
Liver Transpl; 2008 Sep; 14(9):1333-9. PubMed ID: 18756471
[TBL] [Abstract][Full Text] [Related]
6. Emerging indications for albumin dialysis.
Sen S; Williams R; Jalan R
Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
[TBL] [Abstract][Full Text] [Related]
7. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
[TBL] [Abstract][Full Text] [Related]
8. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.
Heemann U; Treichel U; Loock J; Philipp T; Gerken G; Malago M; Klammt S; Loehr M; Liebe S; Mitzner S; Schmidt R; Stange J
Hepatology; 2002 Oct; 36(4 Pt 1):949-58. PubMed ID: 12297843
[TBL] [Abstract][Full Text] [Related]
9. [The clinical experience with MARS and Prometheus procedures].
Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
[TBL] [Abstract][Full Text] [Related]
10. Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management.
Steiner C; Sen S; Stange J; Williams R; Jalan R
Liver Transpl; 2004 Dec; 10(12):1531-8. PubMed ID: 15558653
[TBL] [Abstract][Full Text] [Related]
11. Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
De Bruyn T; Meijers B; Evenepoel P; Laub R; Willems L; Augustijns P; Annaert P
Artif Organs; 2012 Jan; 36(1):29-41. PubMed ID: 21955219
[TBL] [Abstract][Full Text] [Related]
12. An albumin-fixed membrane for the removal of protein-bound toxins.
Ge D; Wu D; Shi W; Ma Y; Tian X; Liang P; Zhang Q
Biomed Mater; 2006 Sep; 1(3):170-4. PubMed ID: 18458399
[TBL] [Abstract][Full Text] [Related]
13. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin.
Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC
Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711
[TBL] [Abstract][Full Text] [Related]
14. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
[TBL] [Abstract][Full Text] [Related]
15. Slow continuous ultrafiltration with bound solute dialysis.
Patzer JF; Safta SA; Miller RH
ASAIO J; 2006; 52(1):47-58. PubMed ID: 16436890
[TBL] [Abstract][Full Text] [Related]
16. Albumin dialysis molecular adsorbents recirculating system: impact of dialysate albumin concentration on detoxification efficacy.
Drexler K; Baustian C; Richter G; Ludwig J; Ramlow W; Mitzner S
Ther Apher Dial; 2009 Oct; 13(5):393-8. PubMed ID: 19788455
[TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation.
Krisper P; Haditsch B; Stauber R; Jung A; Stadlbauer V; Trauner M; Holzer H; Schneditz D
J Hepatol; 2005 Sep; 43(3):451-7. PubMed ID: 16023249
[TBL] [Abstract][Full Text] [Related]
18. Reduction of elevated cytokine levels in acute/acute-on-chronic liver failure using super-large pore albumin dialysis treatment: an in vitro study.
Dominik A; Stange J; Pfensig C; Borufka L; Weiss-Reining H; Eggert M
Ther Apher Dial; 2014 Aug; 18(4):347-52. PubMed ID: 24215331
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.
Wallon G; Guth C; Guichon C; Thevenon S; Gazon M; Viale JP; Schoeffler M; Duperret S; Aubrun F
Blood Purif; 2022; 51(3):243-250. PubMed ID: 34139706
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.
Karvellas CJ; Gibney N; Kutsogiannis D; Wendon J; Bain VG
Crit Care; 2007; 11(3):215. PubMed ID: 17567927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
